Ken Griffin Mimedx Group, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$5.65 - $7.76 $150,290 - $206,416	-26,600 Reduced 76.88%	8,000 $47,000
Q2 2024 Aug 14, 2024	SELL	$6.16 - $8.08 $419,496 - $550,248	-68,100 Reduced 66.31%	34,600 $239,000
Q1 2024 May 15, 2024	BUY	$7.61 - $8.63 $100,452 - $113,916	13,200 Added 14.75%	102,700 $790,000
Q4 2023 Feb 14, 2024	BUY	$5.7 - $9.14 $321,480 - $515,496	56,400 Added 170.39%	89,500 $784,000
Q3 2023 Nov 14, 2023	SELL	$6.35 - $8.16 $25,400 - $32,640	-4,000 Reduced 10.78%	33,100 $241,000
Q2 2023 Aug 14, 2023	BUY	$3.14 - $6.61 $74,104 - $155,996	23,600 Added 174.81%	37,100 $245,000
Q1 2023 May 15, 2023	SELL	$2.97 - $4.81 $5,643 - $9,139	-1,900 Reduced 12.34%	13,500 $46,000
Q4 2022 Feb 14, 2023	SELL	$2.63 - $3.45 $24,985 - $32,775	-9,500 Reduced 38.15%	15,400 $42,000
Q3 2022 Nov 14, 2022	SELL	$2.71 - $4.22 $78,590 - $122,380	-29,000 Reduced 53.8%	24,900 $71,000

209

98.2M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.05B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.